Form 8-K - Current report:
SEC Accession No. 0001178670-25-000076
Filing Date
2025-06-18
Accepted
2025-06-18 16:48:38
Documents
14
Period of Report
2025-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alny-20250612.htm   iXBRL 8-K 29697
2 EX-99.1 a20250618exhibit991.htm EX-99.1 14374
6 logoforera.jpg GRAPHIC 4595
  Complete submission text file 0001178670-25-000076.txt   175673

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alny-20250612.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alny-20250612_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alny-20250612_pre.xml EX-101.PRE 13046
17 EXTRACTED XBRL INSTANCE DOCUMENT alny-20250612_htm.xml XML 2942
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 251057552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)